Monday, 5 October 2020

Sciatica Market Staggering Double Digit Cagr Till 2023

 

Market Highlights

Sciatica is pain going down the leg from the lower back due to irritation of the lumbar or sacral nerves triggered by activities such as heavy lifting, jerky movements etc. Sciatica symptoms generally occur on one side of the body although in some cases it affects both sides. The symptoms include weakness or numbness in the affected leg, burning or tingling down the affected leg, and constant pain on one side of the rear. The causes of sciatica are spondylolisthesis, lumbar degenerative disc disease, osteophytes and arthritis of the spine, muscle spasm in the back or buttock, spinal stenosis, piriformis syndrome, pelvic tumours, pregnancy and others. However spinal disc herniation is the primary cause of sciatica in about 90% of the cases.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4767 

Sciatica generally resolves on its own in about 90% of the cases. However severe sciatica may require surgical intervention if complications such as bowel or bladder problems occur. Sciatica affects 40% of people at some point in their life time and is most common during people's 40s and 50s, with men being more affected than women.

The market drivers for global market are rise in demand due to growing population, increasing screening, rising cases of geriatrics, rising safety and success of drug treatment, the extricating nature of the pain and others. The market restraints are the complications of surgery such as risk of bleeding, infections, pain, high cost of sciatica treatment, and others. 

The market drivers for global market are rise in demand due to growing population and greater number of procedures performed, increasing screening, greater consumption of starch rich diets and fast foods, greater emphasis on restorative dental procedures, rising efficacy, efficiency and success rate of treatment, and others. The market restraints are the complications such as risk of bleeding, infections, pain, high cost of treatment, loss of the tooth due to damaged and weak enamel, risk of developing abscess due to incomplete removal of infected material or if the antibiotics aren’t effective and others.

Product development represents the best strategy for the market growth. The market is expected to witness exponential growth over the review period owing to technological advancement in medical devices such as transcutaneous electrical nerve stimulation. Market development is another strategy for as there is a large unmet need in the developing regions such as India and China. Cost of the product will be a decisive factor in the developing regions such as Asia Pacific and especially Africa.

Global Sciatica Market Players

Some of the key players profiled in the report are Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi and others.

Regional Analysis

The Americas accounts for a significant market share owing to high expenditure on the healthcare especially of the U.S. and Canada. Additionally, the greater number of orthopedic procedures due to greater healthcare penetration in the U.S. and Canada drives the market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgical procedures especially the sciatica treatment in the returns of hospitals favors the market. The large number of medical devices companies in the U.S. is also a cause for the faster development of the market in the US.

Europe is the second largest market in the world due to growing medical devices industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large medical devices industry.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. The South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future market in the region.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Sciatica Market” Research Report – Forecast till 2023.

Segmentation

The global sciatica market has been segmented on the basis of types, drug treatment, devices and end user.

Based on the types, the market has been segmented as L4 nerve root sciatica, L5 nerve root sciatica, S1 nerve root sciatica and others.

Based on the drugs, the market has been segmented as anesthetics, pain killers, muscle relaxants, antidepressants, steroids and others.

Based on the non-drug treatment, the market has been segmented as physiotherapy, acupuncture, stimulation devices, surgery and others.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/sciatica-market-4767 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Integrated Cardiology Devices Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

 Global integrated cardiology device market is expecting enormous growth in coming future. Increasing prevalence of cardiovascular diseases, and growing adoption rates of minimally invasive surgeries and technological advances introduced in this field. Presently 30% of diseases occurring worldwide are cardiac diseases. There are various types of integrated cardiac devices such as Cardiology EMR Software, EHR (Electronic health record), FFR (fractional flow reserve), Optical Coherence Tomography and others which are advanced and most effective in treatment of cardiac diseases. High cost of the devices is mainly causing hindrance to the growth of this market.

Expensive devices are the one of the major restraint for the growth of this market and so is the lack of infrastructure especially in the developing economies. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1189 

Segmentation 

The global integrated cardiology devices market is segmented on the basis of types, applications and end users.

Based on types, the market is segmented as Cardiology EMR Software, EHR (Electronic health record), FFR (fractional flow reserve), Optical Coherence Tomography, others.

On the basis of application, they are segmented sudden cardiac arrest, internal monitoring, Cardiac resynchronization therapy, Cardiothoracic surgery, others. Cardiac Resynchronization Therapy (CRT) is an effective therapy in heart failure.

On the basis of end users, the market is segmented into catheterization laboratories, Hospitals and others. 

Regional Analysis

On regional basis, integrated cardiology devices market is segmented into America, Europe, Asia pacific, Middle East and Africa. For integrated cardiology the market is growing globally, where America accounts for the maximum share due to increasing prevalence of cardiac diseases. According to America’s Center disease control and prevention around 610,000 people die of cardiac diseases that’s 1 in every 4 deaths. Besides increasing expenditure in healthcare and well developed healthcare sector has also driven the growth of the market.

Europe commands for the second leading market which is followed by Asia pacific. Europe has always maintained a strong and well-developed infrastructure, due to increasing cardio-logical problems and eagerness to solve them by using integrated cardiology device market has driven this market in Europe. During the forecasted period, Asia Pacific is expecting fast growth. There are several factors leading to the growth for integrated cardiology devices such government initiation to improve public health and adoption of new therapies. Patients from well-developed nation come to Asian countries like India to get affordable treatments and this factor is forcing the growth of the market. Middle East & Africa showing slow but steady growth in the market due to inadequate development in medical sector and less health care expenditure. 

The major key players in global integrated cardiology devices market are Medtronic (US),  Boston Scientific Corporation (US), Medtronic (US), Jude Medical (US), Edwards Lifesciences Corporation (US), Abbott Laboratories (US), Johnson and Johnson (US), Getinge (Sweden), Terumo Corporation (Japan), Lepumedical (Bejing), Acrostak (Switzerland), Koninklijke Philips N.V. (Netherlands), Athenahealth, Inc. (U.S),others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/integrated-cardiology-devices-market-1189 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Root Canal Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Market Scenario

root canal is a dental procedure involving the removal of the central pulp from the tooth. A root canal is performed when the pulp of a tooth is injured, inflamed or infected. The objective of the root canal is to save the structure of the tooth and to prevent infection of the gums and other teeth. Common causes of the root canal treatment include deep decay due to the cavity, a chip or crack in the tooth, an injury to the tooth, infection, and others. The most common symptoms of damaged pulp include pain, swelling, and a heat sensation in the gums.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4742

A nonsurgical root canal treatment is carried out for managing the infection or inflammation in the tooth. A secondary root canal treatment is carried out when the problem is not solved with the first root canal procedure. An apicoectomy is a microsurgical procedure in which the infected tissue and tip of the root of the tooth are removed due to the failure of the regular root canal treatments. A pulpotomy is the removal of the nerve and diseased pulp from the crown of the tooth with an aim to save the root nerve intact. A pulpectomy is the removal of whole pulp from both the root and crown. According to American Association of Endodontists (AAE), more than 15 million root canals are performed every year and over 41,000 root canals are performed each day, with 89% of patients are satisfied after root canal treatment by an endodontist.

The market drivers for global root canal market are a rising demand due to growing population, increasing screening, greater use of fatty and starch-rich diets and fast foods, greater emphasis on restorative dental procedures, rising safety and success of root canal treatment, and others. The market restraints are the complications such as the risk of bleeding, infections, pain, the high cost of root canal treatment, loss of the tooth due to damaged and weak enamel, the risk of developing abscess due to incomplete removal of infected material or if the antibiotics aren’t effective and others.

The global root canal market is expected to reach USD 21.0 billion by 2023, and the market is projected to grow at a CAGR of ~ 8.0 % during the forecast period 2017-2023.

Key Players in the Global Root Canal Market

Some of the key players profiled in the report are Kerr Corporation, Dentsply Sirona, LM-Instruments Oy, Schütz Dental GmbH, Ultradent Products Inc., Pelton & Crane, 3M, Confident Dental Equipment Ltd., Benco Dental and others.

Intended Audience

  • Global Root canal manufacturers & suppliers
  • Research and development (R&D) companies
  • Hospitals and clinics
  • Academic institutes and universities

Segments

The global root canal market has been segmented on the basis of types, drugs, devices, and end user.

Based on the types, the market has been segmented as a nonsurgical root canal, secondary root canal, apicoectomy root canal, pulpotomy root canal, and pulpectomy root canal.

Based on the drugs, the market has been segmented as anesthetics, painkillers, antibiotics, and others.

Based on the devices, the market has been segmented into crowns, endodontic instruments, consumables, others.

Based on the end user, the market has been segmented as dentistry hospitals and clinics, research and academics, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/root-canal-market-4742  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

World Eye Cancer Market Estimation Of Top Key Players Shares, Revenue, Analysis And Forecasts Till 2023

 

Market Highlights

Although the prevalence of this disease is considered rare. Porphyria is a disorder that occurs when there is a build-up of the chemicals in the body that produce a substance called porphyrin. Acute intermittent porphyria (AIP) is a genetic metabolic disorder is one of the 8 types of porphyria. It affects the production of heme, the oxygen-binding prosthetic group of hemoglobin. Children have a 50% chance of inheriting any of the 8 different types of porphyria if their parents have the disorder.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4736 

Market Highlights

Eye cancers or ocular cancers manifests itself in the eye. Cancer is referred to the uncontrolled growth of the cells, similarly, eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably leading to the formation of tumors. The global eye cancer market is expecting a healthy growth in coming future. The global market is majorly driven by increasing eye cancer patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval, and side effects of the treatment may hinder the growth of the market.

The global eye cancer market is expected to grow at a CAGR of 8.3% during the forecast period 2017-2023. 

Segmentation

The global market is segmented on types, treatment and end users. On the basis of types, the market is segmented into intraocular cancer, squamous cell cancer, rhabdomyosarcoma, and others. Intraocular cancer is further segmented into melanoma of the eye, lymphoma of the eye, and cancers in children. On the basis of treatment, the market is categorised into chemotherapy, surgery & radiation therapy, targeted therapy, hormone therapy, biologic therapy, and other. Chemotherapy is further segmented into anthracyclines, taxanes, antimetabolites, and alkylating agents. Target therapy is sub segmented into monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others. On the basis of end users, the market is segmented into hospital & clinics, ambulatory care centers and others. 

Regional Analysis

The Americas dominate the global market owing to a huge patient population, large geriatric population, high healthcare spending and strong government support for research & development. As per the report of the Centers for Disease Control and Prevention, in 2014, over 14.1 million of new cancer cases were registered worldwide. Increasing prevalence of the disease has boosted the market growth in America. Additionally, changing lifestyle and smoking has fuelled the growth of the market. 

Europe holds the second leading market in global eye cancer market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for eye cancer. Asia Pacific eye cancer market is majorly driven by Japan, India, and China owing to a huge patient pool, and rapidly developing healthcare sector. The Middle East and Africa contribute the least to the growth of global market. The Middle East dominates the market for The Middle East and Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East eye cancer market. However, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region. However the growth of the Africa market is high due to the presence of opportunities for the development of the market. 

Key Players

Some of key the players in the market are Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Amgen, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.),  Sanofi (France), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Oncomed Pharmaceuticals (U.S.) and Immunomedics (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eye-cancer-market-4736 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

World Acute Intermittent Porphyria Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

 

Market Highlights

Although the prevalence of this disease is considered rare. Porphyria is a disorder that occurs when there is a build-up of the chemicals in the body that produce a substance called porphyrin. Acute intermittent porphyria (AIP) is a genetic metabolic disorder is one of the 8 types of porphyria. It affects the production of heme, the oxygen-binding prosthetic group of hemoglobin. Children have a 50% chance of inheriting any of the 8 different types of porphyria if their parents have the disorder.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4713 

Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period 2017-2023.

The global acute intermittent porphyria market is expected to grow at a CAGR of 5.6 % during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global acute intermittent porphyria market owing to the presence of huge patient population with gastrointestinal problems, neurological issues, high healthcare spending, and increasing government support for research & development.  

Europe holds the second largest share of the global acute intermittent porphyria market as result of increasing focus of various government agencies on the treatment of rare diseases such as acquired aplastic anemia. Moreover, the growing public awareness about acquired aplastic anemia likely to boost the Europe market.

Asia Pacific is the fastest growing acute intermittent porphyria market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global acute intermittent porphyria market is segmented on the basis by diagnosis, by treatment, and by end user. On the basis of diagnosis, it is segmented into blood test, urine test, serum test, DNA test, and others.  On the basis of treatment, it is segmented into gonadotropin-releasing hormone analogues, prophylactic hematin infusions, and others. On the basis of end user, it is segmented into hospitals & clinics, research centers, and others.

Key Players

Some of key the players in the market are Dahaner (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc.  (U.S.), Siemens AG (U.S.), ARKRAY, Inc. (Japan), Sysmex Corporation (Japan), and ACON Laboratories, Inc. (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/acute-intermittent-porphyria-market-4713 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Spinal Traction Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2023

 Market Synopsis

According to a new report by Market Research Future (MRFR), the global spinal traction market is expected to reach USD 6.0 billion by the end of 2023. The market is envisaged to witness a steady growth to expand at 7.7 % CAGR over the forecast period (2017-2023) owing to the growing geriatric population. Spinal traction devices are used to stabilize and decompress the spine for treating several spinal disorders and orthopedic conditions like bone fractures, muscle contracture, and bone deformities like kyphosis, scoliosis, and lordosis. These devices are also used in treating low back pain and muscle spasms. Spinal traction devices are also used to prepare patients for surgical procedures like interbody fixation, endoscopic spine surgery, vertebral compression fracture repair, and interspinous fixation.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1902 

Future Drivers and Constraints

Increasing production number of spinal surgery, implants, and ongoing researches for improving the quality of care are expected to create attractive growth opportunities for the market globally. With the increasing cases of trauma and spinal cord diseases, growing geriatric population, increase in the number of spinal surgeries, screening and awareness, and developing healthcare are some of the factors propelling the market growth over the review period.

Also, the shift in the preference among patients and surgeons for adopting minimally invasive (MI) surgery over traditional surgeries have resulted in the development of advanced spinal implants. The rising number of clinical trials of latest technology implants is also propelling the market growth over the assessment period.

Innovation has remained the best strategy with companies focusing on developing new devices which can offer better treatment and diagnostic to various types of spine conditions. Wireless sensor technology is one of the latest researches with advanced products connected to external devices for analysis and healing progress.

Meanwhile, costly devices, lack of experimental clinical data in medical treatment, risk related after surgery which comprises risk of damage and infection to the spine, and demand for minimally invasive procedures is assessed to hamper the growth of the market over the forecast period.

Global Spinal Traction Market Segmentation

The global market for spinal traction has been segmented on the basis of diagnosis, type, treatment, end-users, and region.

The market has been segmented into mechanical spinal traction and manual spinal traction based on types. The market has been segmented into herniated discs, sciatica, facet disease, slipped discs, bone spurs, foraminal stenosis, pinched nerves, and degenerative disc disease, based on applications. The market has been segmented into gravity-dependent traction, manual traction, and continuous traction based on devices.

The market has also been segmented into academic and research, hospitals and clinics, and others based on end-users. Among these, the segment for hospital dominated the global market for spinal traction and is predicted to maintain its dominance over the assessment period.

Regional Analysis

Geographically, the market for spinal traction has been spanned across regions such as North America, the Middle East and Africa, Europe, and Asia Pacific.

The North American region is anticipated to hold the largest market share due to the high expenditure on healthcare. Also, adoption of medical devices and new diagnostics in the U.S. is also expected to drive the market in this region. Moreover, the presence of large hospital networks and major healthcare companies in the developed countries is propelling the market growth over the assessment period.

Europe holds the second largest position after North America, owing to the penetration of strong healthcare and high income in this region. Countries such as France and Germany are expected to lead the market growth in the European region. The UK is anticipated to emerge as the fastest growing market over the review period due to the presence of strong pharmaceutical industry.

Asia Pacific is estimated to grow rapidly over the assessment period. India and China are likely to lead the market owing to the huge unmet requirement and fast-growing healthcare sector over the assessment period. Moreover, South East Asian countries like India, China, and Malaysia are estimated to contribute to the market growth. Also, increasing penetration of healthcare insurance in the Asia Pacific region is anticipated to spur the market growth in this region.

Moreover, the UAE and Saudi Arabia are anticipated to drive the Middle East and African market. The African region is expected to witness moderate growth due to poor political and economic conditions.

Industry News

Natural compounds derived from Australian plants have been found to stimulate cells and are useful for transplantation to repair injuries in the spinal cord. The results have been published in the Scientific Reports by a team of scientists recently at the Menzies Health Institute Queensland and Griffith Institute for Drug Discovery.

Competition Analysis

 The prominent players operating the spinal traction market are Stoll Medizintechnik GmbH, Spinal Designs International Inc., Saunders Group Inc., SpineRx Technology, VAX-D Medical Technologies LLC., Scrip, Inc. BTL, North American Medical (NAM) Corporation, Spinetronics, LLC, Dentsply International, Medtronic Inc., CERT Health Sciences LLC, Hill Laboratories Company, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/spinal-traction-market-1902 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

North America Dental consumables Market Positive Growth And Forecasts By 2023

 

North America Dental Consumables Market- Overview

The North America Dental Consumables Market is growing with a rapid pace. According to a recent study report published by the Market Research Future, the North America Dental Consumables Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017-2023).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4612 

Dental Consumables are a category of products that are used on patients by dental practioners or dentists in order to treat and /or perform procedures associated with preventive, restorative, diagnostic and emergency oral health issues. Factors such as increasing prevalence of dental diseases and rising number of dental procedures are the major drivers for the market growth. According to the American Dental Association, in 2014, 52.3% of adults reported to visit the dentist in every six months, 15.4% reported once per year, and 11.0% reported once every two to three years. Moreover, according to the Centres for Disease Control and Prevention, in 2014, 19% of the children aged 5-19 years and 31% of adults aged 20-44 have untreated dental caries. Additionally, growing geriatric population is fuelling the market growth. However, poor reimbursement policies and gray market of dental distribution are estimated to restrain the market growth during the forecast period. According to the National Coalition on Health Care, in 2012, American families spent an average of USD 9,000 on out-of-pocket health insurance and other medical costs like co-pays and deductibles.

North America Dental Consumables Market- Competitive Analysis

Institut Straumann AG, Henry Schein, Inc., Patterson Dental Supply, Inc., Dentsply Sirona, Kerr Corporation, Danaher Corporation, GC orthodontics, Planmeca Oy, and American Orthodontics, and others are some of the prominent players at the forefront of competition in the North America Dental Consumables Market and are profiled in MRFR Analysis. 

Characterized by the presence of several well-established and small players, the North America Dental Consumables Market appears to be highly competitive and fragmented. International players are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In August, 2016- Henry Schein announced that it will acquire 80% ownership of Marrodent, which is a full service dental distributer of Poland, thus marking Henry Schein’s entry into the dental market of Poland.

In July, 2016- Kitron signs supply agreement with Dentsply Sirona. This agreement will add Kitron as a new supplier for Dentsply Sirona.

In April, 16- Straumann acquired 51% residual ownership of Neodent. This deal augments Straumann's presence in the tooth replacement sector in the Latin American region and Brazil, which is the second largest market for implant dentistry.

In February, 16- Septodont signed an agreement with Egalet Corporation, a specialty pharmaceutical company, for exclusive marketing rights to promote Sprix nasal spray to the dental market in the United States.

In May, 16- Knifeless Tech Systems was acquired by 3M. The business acquired is an installation tool used to cut self-adhesive films applied to vehicle wraps.

In February, 16- Septodont acquired DLA, an injectable dental anaesthetic manufacturing plant from Dentsply International.

In February, 16- DENTSPLY International Inc. and Sirona Dental Systems, Inc. Announce Completion of Remaining Regulatory Milestones for Proposed Merger.

North America Dental Consumables Market- regional analysis

Regionally, North America is divided into the U.S. and Canada. The U.S. is estimated to lead the North America Dental Consumables Market owing to high expenditure on the health care within the region. Moreover, the fastest uptake of new products in the U.S drives the dental consumables market. Additionally, concentration of the major healthcare companies in the developed economies of this region coupled with large insurance penetration is also adding fuel to the market growth.

FOR MORE DETAILS –https://www.marketresearchfuture.com/reports/north-america-dental-consumables-market-4612 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com